Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Jaro1977on Jul 28, 2020 8:25pm
118 Views
Post# 31334336

RE:RE:AGM Set For Sept 24, 2020

RE:RE:AGM Set For Sept 24, 20201 ISIN: CA88337V1004 CUSIP: 88337V100

2 Date Fixed for the Meeting: September 24, 2020

3 Record Date for Notice: August 21, 2020

4 Record Date for Voting: August 21, 2020

5 Beneficial Ownership Determination Date: August 21, 2020

6 Classes or Series of Securities that entitle COMMON the holder to receive Notice of the Meeting:

7 Classes or Series of Securities that entitle COMMON the holder to vote at the meeting:

8 Business to be conducted at the meeting: Annual and Special

9 Notice-and-Access:
Registered Shareholders: NO
Beneficial Holders: NO
Stratification Level: Not Applicable

10 Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners: YES

11 Issuer paying for delivery to Objecting Beneficial Owners: NO
<< Previous
Bullboard Posts
Next >>